Your genetic code is not as logical as it could be. What if we could rewrite our genetic code, and make it more efficient, sensical and organized? Join Hank and dive deep into genetics in this fun ...

Researchers from CSIRO, Australia's national science agency, have unlocked the most detailed genetic blueprint yet of a major soil-borne crop pathogen—an advance that paves the way for better crop ...

In 2023, the website then known as Twitter partially open sourced its algorithm for the first time. In those days, Tesla billionaire Elon Musk had only recently acquired the platform, and he claimed ...

Elon Musk's X on Tuesday released its source code for the social media platform's feed algorithm. X's source code release is one of the first ever made by a large social platform, Cryptonews.com ...

Elon Musk says social platform X will open-source a new recommendation algorithm within seven days, exposing all code behind organic and ad post suggestions and updating it every four weeks with ...

He open-sourced Twitter’s algorithm back in 2023, but then never updated the GitHub. He open-sourced Twitter’s algorithm back in 2023, but then never updated the GitHub. is the Verge’s weekend editor.

Brenna Henn had a long-term grant to study the genetic diversity of Africans and people of African descent. Then her N.I.H. funding was cut. Credit...Andri Tambunan for The New York Times Supported by ...

A team of researchers at the Broad Institute, led by gene-editing pioneer David Liu, has developed a new genome-editing strategy that could potentially lead to a one-time treatment for multiple ...

PythoC lets you use Python as a C code generator, but with more features and flexibility than Cython provides. Here’s a first look at the new C code generator for Python. Python and C share more than ...

Microsoft has added official Python support to Aspire 13, expanding the platform beyond .NET and JavaScript for building and running distributed apps. Documented today in a Microsoft DevBlogs post, ...

Fulgent Genetics is rated Hold due to strong diagnostic revenue growth but an unproven transition into integrated precision medicine. FLGT's diagnostics business leads with rapid genome tests and ...